StockData
Bausch Health Companies Inc. logo

Bausch Health Companies Inc. (BHC) stock

BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3076% below fair value
$8.73+0.26 (+3.07%)

Close on Nov 18, 2026Market cap $3.27BP/E –Yield –

Bausch Health Companies revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Bausch Health Companies's revenue for the twelve months ending Sep 30, 2026 was $11.11B, up 10.8% year over year. For fiscal 2025 it was $10.27B, up 6.7% from the year before. Over ten years it grew -0.2% a year on average. The highest annual figure on record is $10.45B in fiscal 2015.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$10.27B+6.7%
FY2024Dec 31, 2024$9.63B+9.9%
FY2023Dec 31, 2023$8.76B+7.8%
FY2022Dec 31, 2022$8.12B-3.7%
FY2021Dec 31, 2021$8.43B+5.1%
FY2020Dec 31, 2020$8.03B-6.7%
FY2019Dec 31, 2019$8.60B+2.6%
FY2018Dec 31, 2018$8.38B-3.9%
FY2017Dec 31, 2017$8.72B-9.8%
FY2016Dec 31, 2016$9.67B-7.4%
FY2015Dec 31, 2015$10.45B+27.3%
FY2014Dec 31, 2014$8.21B+42.2%
FY2013Dec 31, 2013$5.77B+65.8%
FY2012Dec 31, 2012$3.48B+43.4%
FY2011Dec 31, 2011$2.43B+105.5%
FY2010Dec 31, 2010$1.18B+44.0%
FY2009Dec 31, 2009$820.43M+8.4%
FY2008Dec 31, 2008$757.18M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$2.94B+9.7%
Q2 FY2026Jun 30, 2026$2.85B+12.7%
Q1 FY2026Mar 31, 2026$2.52B+11.7%
Q4 FY2025Dec 31, 2025$2.80B+9.3%
Q3 FY2025Sep 30, 2025$2.68B+6.8%
Q2 FY2025Jun 30, 2025$2.53B+5.3%
Q1 FY2025Mar 31, 2025$2.26B+4.9%
Q4 FY2024Dec 31, 2024$2.56B+6.3%
Q3 FY2024Sep 30, 2024$2.51B+12.2%
Q2 FY2024Jun 30, 2024$2.40B+10.9%
Q1 FY2024Mar 31, 2024$2.15B+10.8%
Q4 FY2023Dec 31, 2023$2.41B+9.8%
Q3 FY2023Sep 30, 2023$2.24B+9.4%
Q2 FY2023Jun 30, 2023$2.17B+10.2%
Q1 FY2023Mar 31, 2023$1.94B+1.4%
Q4 FY2022Dec 31, 2022$2.19B-0.1%
Q3 FY2022Sep 30, 2022$2.05B-3.1%
Q2 FY2022Jun 30, 2022$1.97B-6.3%
Q1 FY2022Mar 31, 2022$1.92B-5.4%
Q4 FY2021Dec 31, 2021$2.20B-0.8%
Q3 FY2021Sep 30, 2021$2.11B-1.3%
Q2 FY2021Jun 30, 2021$2.10B+26.2%
Q1 FY2021Mar 31, 2021$2.03B+0.7%
Q4 FY2020Dec 31, 2020$2.21B-0.5%
Q3 FY2020Sep 30, 2020$2.14B-3.2%
Q2 FY2020Jun 30, 2020$1.66B-22.7%
Q1 FY2020Mar 31, 2020$2.01B-0.2%
Q4 FY2019Dec 31, 2019$2.22B+4.9%
Q3 FY2019Sep 30, 2019$2.21B+3.4%
Q2 FY2019Jun 30, 2019$2.15B+1.1%
Q1 FY2019Mar 31, 2019$2.02B+1.1%
Q4 FY2018Dec 31, 2018$2.12B-1.9%
Q3 FY2018Sep 30, 2018$2.14B-3.7%
Q2 FY2018Jun 30, 2018$2.13B-4.7%
Q1 FY2018Mar 31, 2018$2.00B-5.4%
Q4 FY2017Dec 31, 2017$2.16B-10.0%
Q3 FY2017Sep 30, 2017$2.22B–
Q2 FY2017Jun 30, 2017$2.23B–
Q1 FY2017Mar 31, 2017$2.11B–
Q4 FY2016Dec 31, 2016$2.40B–

More Bausch Health Companies figures

See a number that looks wrong?